KATO Pharmaceuticals, Inc.

Susan Wade signed KATO Pharmaceuticals, Inc.'s 2025 Form 5500 as plan administrator.

• Susan Wade — Plan Administrator — Form 5500 signer

Signer names are public record from the Form 5500 e-signature.

KATO Pharmaceuticals, Inc.'s EIN is 45-2899951.

Download the official 2025 Form 5500 (PDF) for KATO Pharmaceuticals, Inc. from the U.S. Department of Labor's EFAST2 system.

KATO Pharmaceuticals, Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, automatic enrollment, a default investment (QDIA).